Cargando…

COVID-19 and hyperglycemia/diabetes

In early studies regarding coronavirus disease 2019 (COVID-19), type 2 diabetes mellitus was considered to contribute substantially to the disease’s inflammatory response. Subsequently, even hyperglycemia, regardless of insulin resistance or diabetes mellitus, was found to be additionally harmful. R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michalakis, Konstantinos, Ilias, Ioannis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107977/ https://www.ncbi.nlm.nih.gov/pubmed/33995851 http://dx.doi.org/10.4239/wjd.v12.i5.642

Ejemplares similares

Challenges in hyperglycemia management in critically ill patients with COVID-19
por: Kethireddy, Rajesh, et al.
Publicado: (2022)

Liver function in transgender persons: Challenges in the COVID-19 era
por: Milionis, Charalampos, et al.
Publicado: (2023)

Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19
por: Ilias, Ioannis, et al.
Publicado: (2021)

Novel appearance of hyperglycemia/diabetes, associated with COVID-19
por: Ilias, Ioannis
Publicado: (2022)

Treatment on Nature’s lap: Use of herbal products in the management of hyperglycemia
por: Giri, Somdatta, et al.
Publicado: (2023)

Intermediate hyperglycemia in early pregnancy: A South Asian perspective
por: Punnose, John, et al.
Publicado: (2023)

Replication mechanisms of circular ssDNA plant viruses and their potential implication in viral gene expression regulation
por: Bonnamy, Mélia, et al.
Publicado: (2023)

COVID-19 vaccination and diabetic ketoacidosis
por: Joob, Beuy, et al.
Publicado: (2023)

Progesterone in gender-affirming therapy of trans women
por: Milionis, Charalampos, et al.
Publicado: (2022)

Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity
por: Gangadharan, Charitha, et al.
Publicado: (2021)

Pediatric transplantation during the COVID-19 pandemic
por: Kakos, Christos Dimitrios, et al.
Publicado: (2022)

COVID-19 associated diabetes mellitus: A review
por: Gavkare, Ajay M, et al.
Publicado: (2022)

Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms
por: Ilias, Ioannis, et al.
Publicado: (2020)

Liver transplantation during COVID-19: Adaptive measures with future significance
por: Gyftopoulos, Argyrios, et al.
Publicado: (2022)

Network meta-analyses: Methodological prerequisites and clinical usefulness
por: Christofilos, Savvas Ilias, et al.
Publicado: (2022)

COVID-19 and the cardiovascular system-current knowledge and future perspectives
por: Chatzis, Dimitrios G, et al.
Publicado: (2022)

Diabetes mellitus and COVID-19: Understanding the association in light of current evidence
por: Sen, Saikat, et al.
Publicado: (2021)

Multiple immune function impairments in diabetic patients and their effects on COVID-19
por: Lu, Zhong-Hua, et al.
Publicado: (2021)

Children with type 1 diabetes in COVID-19 pandemic: Difficulties and solutions
por: Shi, Yue, et al.
Publicado: (2022)

SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects
por: Michalakis, Konstantinos, et al.
Publicado: (2020)

Telemedicine in the COVID-19 era: Taking care of children with obesity and diabetes mellitus
por: Umano, Giuseppina Rosaria, et al.
Publicado: (2021)

Alphabet strategy for diabetes care: A checklist approach in the time of COVID-19 and beyond
por: Upreti, Rajeev, et al.
Publicado: (2021)

Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare
por: Bilic Curcic, Ines, et al.
Publicado: (2021)

Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy
por: Vasilev, Georgi, et al.
Publicado: (2022)

Chest radiological finding of COVID-19 in patients with and without diabetes mellitus: Differences in imaging finding
por: Gangadharan, Sunay, et al.
Publicado: (2022)

Multiple influences of the COVID-19 pandemic on children with diabetes: Changes in epidemiology, metabolic control and medical care
por: Zucchini, Stefano, et al.
Publicado: (2023)

Overcoming ischemia in the diabetic foot: Minimally invasive treatment options
por: Spiliopoulos, Stavros, et al.
Publicado: (2021)

Colonoscopy attachments for the detection of precancerous lesions during colonoscopy: A review of the literature
por: Gkolfakis, Paraskevas, et al.
Publicado: (2018)

Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients
por: Rojas, Armando, et al.
Publicado: (2021)

MicroRNA-155 mediates endogenous angiotensin II type 1 receptor regulation: implications for innovative type 2 diabetes mellitus management
por: Papadopoulos, Konstantinos I, et al.
Publicado: (2023)

Impact of COVID-19 on liver
por: Su, Yu-Jang, et al.
Publicado: (2021)

Phytochemicals for the treatment of COVID-19
por: Españo, Erica, et al.
Publicado: (2021)

Abdominal imaging in COVID-19
por: Balaban, Daniel Vasile, et al.
Publicado: (2021)

COVID-19 and gastroenteric manifestations
por: Chen, Zhang-Ren, et al.
Publicado: (2021)

COVID-19: Where is the treatment?
por: Sabeerabi, Bonala, et al.
Publicado: (2021)

COVID-19 impact on the liver
por: Baroiu, Liliana, et al.
Publicado: (2021)

COVID-19 and gut immunomodulation
por: Roy, Koushik, et al.
Publicado: (2021)

Air leaks in COVID-19
por: Juneja, Deven, et al.
Publicado: (2022)

Antenatal corticosteroids in COVID-19 perspective
por: Vidaeff, Alex C, et al.
Publicado: (2021)

Gastrointestinal mucosal immunity and COVID-19
por: Velikova, Tsvetelina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1dncajrgahmnb8rt6sf46gi0hp